These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1621789)

  • 1. Therapeutic index of epinephrine and dipivefrin with nasolacrimal occlusion.
    Zimmerman TJ; Sharir M; Nardin GF; Fuqua M
    Am J Ophthalmol; 1992 Jul; 114(1):8-13. PubMed ID: 1621789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasolacrimal occlusion improves the therapeutic index of antiglaucoma medications.
    Sharir M; Zimmerman TJ
    J Assoc Acad Minor Phys; 1994; 5(2):62-7. PubMed ID: 8032178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic index of pilocarpine, carbachol, and timolol with nasolacrimal occlusion.
    Zimmerman TJ; Sharir M; Nardin GF; Fuqua M
    Am J Ophthalmol; 1992 Jul; 114(1):1-7. PubMed ID: 1621773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An advance in ophthalmic pharmacology. The use of the epinephrine pro-drug dipivalyl epinephrine in the treatment of glaucoma.
    Garzia R
    J Am Optom Assoc; 1982 Sep; 53(9):727-30. PubMed ID: 7130613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipivefrin: current concepts.
    Goldberg I; Kolker AE; Kass MA; Becker B
    Aust J Ophthalmol; 1980 May; 8(2):147-50. PubMed ID: 7004425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of nasolacrimal canal blockage on topical medications for glaucoma.
    Aritürk N; Oge I; Erkan D; Süllü Y; Sahin M
    Acta Ophthalmol Scand; 1996 Aug; 74(4):411-3. PubMed ID: 8883562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of the combination of l-moprolol and dipivefrin in reducing the intraocular pressure in primary open-angle glaucoma or in ocular hypertension.
    Rossetti L; Barbieri P; Velati P; Bujtar E; Orzalesi N
    Graefes Arch Clin Exp Ophthalmol; 1994 Nov; 232(11):670-4. PubMed ID: 7843592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Guanethidine/dipivefrin and pilocarpine in the treatment of increased intraocular pressure].
    Ober M; Scharrer A; Dausch D
    Klin Monbl Augenheilkd; 1987 Feb; 190(2):103-4. PubMed ID: 3573660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-masked comparison of betaxolol and dipivefrin for the treatment of increased intraocular pressure.
    Albracht DC; LeBlanc RP; Cruz AM; Lamping KA; Siegel LI; Stern KL; Kelley EP; Stoecker JF
    Am J Ophthalmol; 1993 Sep; 116(3):307-13. PubMed ID: 8357055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corneal vascularization and opacification during long-term use of dipivefrin.
    Salminen L; Krootila K; Helin H; Hakala T
    J Ocul Pharmacol Ther; 1995; 11(1):37-40. PubMed ID: 8535955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipivefrin and epinephrine treatment of elevated intraocular pressure: a comparative study.
    Kass MA; Mandell AI; Goldberg I; Paine JM; Becker B
    Arch Ophthalmol; 1979 Oct; 97(10):1865-6. PubMed ID: 39539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experiences with the effectiveness and tolerance of guanethidine/dipivefrin-AT in the treatment of increased intraocular pressure].
    Ober M; Scharrer A
    Klin Monbl Augenheilkd; 1986 Jan; 188(1):64-6. PubMed ID: 3959479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipivefrin and echothiophate. Efficacy of combined use in human beings.
    Mindel JS; Yablonski ME; Tavitian HO; Podos SM; Orellana J
    Arch Ophthalmol; 1981 Sep; 99(9):1583-6. PubMed ID: 7283808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levobunolol compared to dipivefrin in African American patients with open angle glaucoma.
    Drake MV; Wilson MR; Harris D; Goodwin L
    J Ocul Pharmacol; 1993; 9(2):91-5. PubMed ID: 8123096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of primary open-angle glaucoma by oftan-dipivefrin].
    Egorov EA; Alekseev VN; Erichev VP; Usachev VV; Simonova SV; Iakubova LV
    Vestn Oftalmol; 2000; 116(1):32-3. PubMed ID: 10741262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of latanoprost and dipivefrin, alone or combined, on intraocular pressure and on blood-aqueous barrier permeability.
    Widengård I; Mäepea O; Alm A
    Br J Ophthalmol; 1998 Apr; 82(4):404-6. PubMed ID: 9640189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is it worthwhile to add dipivefrin HCl 0.1% to topical beta 1-, beta 2-blocker therapy?
    Parrow KA; Hong YJ; Shin DH; Shi DX; McCarty B
    Ophthalmology; 1989 Sep; 96(9):1338-41; discussion 1341-2. PubMed ID: 2571114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two treatment schedules for combined timolol and dipivefrin therapy.
    Tsoy EA; Meekins BB; Shields MB
    Am J Ophthalmol; 1986 Sep; 102(3):320-4. PubMed ID: 3529971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dipivefrin: its mechanism of action, clinical efficacy and good tolerance].
    Harper DG; Novack GD; Borrmann LR; Branin MJ
    Ophtalmologie; 1989; 3(4):306-7. PubMed ID: 2641142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of adding betaxolol to dipivefrin therapy.
    Weinreb RN; Ritch R; Kushner FH
    Am J Ophthalmol; 1986 Feb; 101(2):196-8. PubMed ID: 3946535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.